SCHEMBL4944355

SCHEMBL4944355

O=C(O)c1c(C(=O)O)c2ccc3ccc4ccc5ccc6ccc1c1c6c5c4c3c21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.41
MEN1 O00255 5/20 0.41
KDM4E B2RXH2 5/20 0.41
HSD17B10 Q99714 4/20 0.41
ALDH1A1 P00352 4/20 0.41
CYP1A2 P05177 3/20 0.41
HPGD P15428 3/20 0.41
GLA P06280 2/20 0.41
CYP2C19 P33261 1/20 0.41
PIM1 P11309 1/20 0.39
CSNK2A2 P19784 1/20 0.39
CSNK2B P67870 1/20 0.39
CSNK2A1 P68400 1/20 0.39
CSNK2A3 Q8NEV1 1/20 0.39
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
CA14 Q9ULX7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9167861 1.00 KMT2A (0.41) KMT2AMEN1KDM4EHSD17B10ALDH1A1
SCHEMBL11928220 0.93 KMT2A (0.38) KMT2AMEN1KDM4EHSD17B10ALDH1A1
SCHEMBL9618164 0.93 KMT2A (0.38) KMT2AMEN1KDM4EHSD17B10ALDH1A1
SCHEMBL28471302 0.91 KMT2A (0.36) KMT2AMEN1KDM4EHSD17B10ALDH1A1
SCHEMBL8042274 0.88 KMT2A (0.35) KMT2AMEN1KDM4EHSD17B10ALDH1A1
SCHEMBL7101315 0.85 ALDH1A1 (0.52) KMT2AMEN1KDM4EHSD17B10ALDH1A1
SCHEMBL275486 0.82 KMT2A (0.53) KMT2AMEN1KDM4EHSD17B10ALDH1A1
SCHEMBL9428595 0.79 KMT2A (0.45) KMT2AMEN1KDM4EHSD17B10ALDH1A1
SCHEMBL29420376 0.79 KMT2A (0.45) KMT2AMEN1KDM4EHSD17B10ALDH1A1
SCHEMBL29500277 0.79 KMT2A (0.45) KMT2AMEN1KDM4EHSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113104843-B Graphene and preparation method thereof 雷索新材料(苏州)有限公司 2022-10-11 CN claimed
CN-113104843-A Graphene and preparation method thereof 雷索新材料(苏州)有限公司 2021-07-13 CN claimed
CN-113104843-B Graphene and preparation method thereof 雷索新材料(苏州)有限公司 2022-10-11 CN disclosed
CN-113104843-A Graphene and preparation method thereof 雷索新材料(苏州)有限公司 2021-07-13 CN disclosed
US-7459317-B2 Method for detecting an analyte in a sample ALVERIX, INC. (US) 2008-12-02 US disclosed
US-20080003622-A1 Methods for detecting an analyte in a sample AVAGO TECHNOLOGIES GENERAL IP (SINGAPORE) PTD. LTD. (SG) 2008-01-03 US disclosed
US-20080003621-A1 Method for Detecting an Analyte in a Sample AVAGO TECHNOLOGIES GENERAL IP (SINGAPORE) PTD. LTD. (SG) 2008-01-03 US disclosed
US-7226752-B1 Methods for detecting an analyte in a sample AVAGO TECHNOLOGIES GENERAL IP (SINGAPORE) PTE. LTD. (SG) 2007-06-05 US disclosed
EP-0693552-B1 Analytical element, composition and method using modified apo-horseradish peroxidase JOHNSON & JOHNSON CLIN DIAG (US) 2003-04-02 EP disclosed
US-6322992-B1 CONTACTING FLUID SAMPLE SUSPECTED OF CONTAINING SPECIFIC BINDING LIGAND WITH AN ANALYTIC ELEMENT CONTAINING VANADIUM BROMOPEROXIDASE-LABELED LIGAND OR ANALOG, AND IMMOBILIZED RECEPTOR THAT BINDS LIGAND OR ANALOG; APPLYING WASH SOLUTION JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. 2001-11-27 US disclosed
EP-0892855-B1 USE OF VANADIUM BROMOPEROXIDASE AS A SIGNAL-GENERATING ENZYME FOR CHEMILUMINESCENT SYSTEMS: TEST KITS AND ANALYTICAL METHODS ORTHO CLINICAL DIAGNOSTICS INC (US) 2001-11-07 EP disclosed
EP-0653637-A2 Dry elements, test devices, test kits and methods for chemiluminescent detection of analytes using peroxidase labeled reagents EASTMAN KODAK COMPANY (US) 1995-05-17 EP disclosed
US-5372931-A Use of 4'-hydroxy- and 4'-alkoxy-substituted electron transfer agents in compositions, elements, test kits and analytical methods EASTMAN KODAK COMPANY (US) 1994-12-13 US disclosed
US-5372932-A Peroxidase-labeled immunoreactant; stabiliztion with a 4-hydroxy or 4-alkoxyarylacetamide EASTMAN KODAK COMPANY (US) 1994-12-13 US disclosed
EP-0603953-A1 Use of 4' of 5'-hydroxy and 4'- or 5'-alkoxy-substituted electron transfer agents in compositions, elements, test kits and analytical methods Johnson & Johnson Clinical Diagnostics, Inc. (US) 1994-06-29 EP disclosed
EP-0603954-A2 Analytical element and immunoassay using a 4-hydroxy or 4-alkoxyarylacetamide as stabilizer Johnson & Johnson Clinical Diagnostics, Inc. (US) 1994-06-29 EP disclosed
EP-0582339-A2 Chemiluminescent composition containing cationic surfactants or polymers and 4'hydroxyacetanilide, test kits and their use in analytical methods Johnson & Johnson Clinical Diagnostics, Inc. (US) 1994-02-09 EP disclosed
US-5279940-A Containing 2,3-dihydro-1,4-phthalazinedione, cationic surfactant, and 4*-hydroxyacetanilide EASTMAN KODAK COMPANY (US) 1994-01-18 US disclosed
US-4668766-A Preparation of thermosettable polymer or prepolymer from heterocyclic material containing nitrogen atoms, carboxylic acid mono- or dianhydride and a polymerizable material with ethylenically unsaturated group THE DOW CHEMICAL COMPANY (US) 1987-05-26 US disclosed
US-4511445-A PARTICLE IRRADIATION AT&T BELL LABORATORIES (US) 1985-04-16 US disclosed